# Jeremy Segal

Các tập podcast hàng đầu
Đã cập nhật:

How to Close M&A Deals in 30 Days

Jeremy Segal, Executive Vice President Corporate Development at Progress (NASDAQ: PRGS) When it comes to M&A, time is of the essence. As a buyer, it's best to identify whether to pursue the deal or not as soon as possible, to avoid wasting money and time. Also, if the seller is a good target compa…

First Conversation to LOI Session 1

Jeremy Segal, Executive Vice President Corporate Development at Progress (NASDAQ: PRGS) Deal origination requires a well-planned strategy, and starts with informal conversations with a potential target. In this episode of the M&A Science Podcast, Jeremy Segal, Executive Vice President of Corpor…

How to Source Deals and Build Your Pipeline

Jeremy Segal, Executive Vice President Corporate Development at Progress NASDAQ: PRGS Corporate development teams are tasked with finding potential M&A targets. And while that may sound fun and exciting, deals don't just fall out of the sky. Any serious acquirer knows that inbound deals are not …

How to Build and Align a Corporate Development Team with Multiple Mandates

On this episode of M&A Science, Kison talks with Jeremy Segal, Senior Vice President of Corporate Development at Progress, about building and aligning a corporate development team with multiple mandates. Jeremy's a Corporate development executive with 20+ years of experience in the technology indu…

S2 Ep42: Medical Crossfire®: Expert Perspectives on c-MET and MET Targeting in NSCLC—Unveiling the Complexities of MET Dysregulation

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode DescriptionIn this podcast, experts Alex A. Adjei, MD, PhD, FACP; Sandip Patel, MD, FASCO; and Jeremy Segal, MD, PhD, discuss the emerging data and clinical strategies for targeting…

The Lesson of Consequences for the Politicization of Law Enforcement

Jeremy Segal from Operations joins in the show to discuss his consumer choices. A listener call-in question on Democratic New York City mayoral candidate Zohran Mamdani’s father’s new book “Slow Poison” on Ugandan dictator Idi Amin. The lesson of consequences for the politicization of law enforceme…

When Deals Get Weird: Stories You Don't See in the CIM

Nathan Rust, Lutz Lehmann, Troy Pospisil, Jeremy Segal, Patrick Mumman, Tej Brahmbhatt, George Helock, and Angie Astle Eight deal professionals share the M&A moments that never make the CIM. A birthday cake in a management presentation that confirmed a culture fit and influenced a bid. A buyer who…

When Deals Get Weird: Stories You Don't See in the CIM

Nathan Rust, Lutz Lehmann, Troy Pospisil, Jeremy Segal, Patrick Mumman, Tej Brahmbhatt, George Helock, and Angie Astle Eight deal professionals share the M&A moments that never make the CIM. A birthday cake in a management presentation that confirmed a culture fit and influenced a bid. A buyer who…

How to Build a Deal Model That Beats PE on Price

Jeremy Segal, Executive Vice President of Corporate Development, Progress (NASDAQ: PRGS) Buyers who mistake a high LOI bid for a winning strategy are easy prey for sellers who know the growth equity playbook. Jeremy Segal's position: precision at the LOI stage is a stronger differentiator than pr…

How to Build a Deal Model That Beats PE on Price

Jeremy Segal, Executive Vice President of Corporate Development, Progress (NASDAQ: PRGS) Buyers who mistake a high LOI bid for a winning strategy are easy prey for sellers who know the growth equity playbook. Jeremy Segal's position: precision at the LOI stage is a stronger differentiator than pr…